For example, engineering the YTS NK cell line to co-express an anti-EGFRvIII CAR and CXCR4 led to enhanced NK cell infiltration and improved survival in glioblastoma xenograft models overexpressing CXCL12 (133). Here, CXCL12 is linked to glioblastoma.